时空之星 | 专注癌症治疗!甫康生物拟港股IPO

有连云
Sep 01, 2025

2025年8月31日,甫康生物科技(上海)股份有限公司正式向香港交易所递交主板上市申请,农银国际、民银资本及复星国际资本担任本次上市的联席保荐人。此举标志着这家专注于癌症治疗领域的生物医药公司迈出了进入资本市场的重要一步。据港交所披露的文件显示,甫康药业成立于2015年11月,是一家以开发突破性疗法为愿景、高效率创新为驱动的商业化阶段生物医药公司。公司专注于开发癌症相关疾病治疗领域的突破性疗法,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10